Aequitas: Guangdong True Health Medical Technology Development Pre-IPO Tearsheet

130 Views12 Jun 2026 10:42

Guangdong True Health Medical Technology Development Co. Ltd. (GTH) plans to raise around US$100m in its upcoming Hong Kong IPO. The deal will be run by CICC, DBS Asia, Zhongtai and Daiwa Capital.

What is covered in the Full Insight:

Introduction to GTH
Market Leadership and Product Offering
Company Background and Milestones
Ownership and Shareholding Structure
Financial Summary and IPO Details

Kajal Jain

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 2-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream

Aequitas: Guangdong True Health Medical Technology Development Pre-IPO Tearsheet
12 Jun 2026